Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Robarts Research Institute, |
RCV000408762 | SCV000484826 | uncertain significance | Hypercholesterolemia, familial, 1 | criteria provided, single submitter | clinical testing | ||
Invitae | RCV001837887 | SCV001411794 | likely benign | Hypercholesterolemia, autosomal dominant, type B; Familial hypobetalipoproteinemia 1 | 2023-03-20 | criteria provided, single submitter | clinical testing | |
Gene |
RCV003328581 | SCV004035661 | uncertain significance | not provided | 2023-09-15 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV003328581 | SCV004220827 | uncertain significance | not provided | 2023-07-21 | criteria provided, single submitter | clinical testing | To the best of our knowledge, this variant has not been reported in the published literature. The frequency of this variant in the general population, 0.0002 (5/24964 chromosomes (Genome Aggregation Database, http://gnomad.broadinstitute.org)), is uninformative in the assessment of its pathogenicity. Analysis of this variant using bioinformatics tools for the prediction of the effect of amino acid changes on protein structure and function yielded conflicting predictions that this variant is benign or damaging. Based on the available information, we are unable to determine the clinical significance of this variant. |